Home / Tag: ARCT-810

Tag Archives: ARCT-810

Arcturus Therapeutics to Develop ARCT-810 for Treatment of Ornithine Transcarbamylase (OTC) Deficiency

San Diego CA—  Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare,  liver and respiratory diseases with ...

Read More »